Francesca Holt
Clinical Oncology Research Fellow and Clinical Oncology Registrar and DPhil Student
Francesca Holt studied medicine at the University of Cambridge and is currently training as a Clinical Oncology Registrar at the Churchill Hospital. She is working towards a DPhil in Population Health under the supervision of Associate Professor Carolyn Taylor, Dr Frances Duane and Dr Georgios Ntentas within CTSU. She is involved in projects aiming to estimate the benefits and risks of different types of adjuvant radiotherapy for early breast cancer.
Recent publications
-
Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes.
Journal article
Holt F. et al, (2023), Int J Radiat Oncol Biol Phys
-
Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality.
Journal article
Kerr AJ. et al, (2022), Cancer Treat Rev, 105
-
Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19.
Journal article
Várnai C. et al, (2022), JAMA Netw Open, 5
-
Proton beam therapy for early breast cancer: a systematic review and quantitative synthesis of adverse clinical outcomes
Journal article
Holt F. et al, (2022), EUROPEAN JOURNAL OF CANCER, 175, S46 - S47
-
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study.
Journal article
Lee LYW. et al, (2020), Lancet Oncol, 21, 1309 - 1316